A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma

Clinical trial NCT00242359 · WITHDRAWN

Trial details

NCT number: NCT00242359
Sponsor: Bernstein Clinical Research Center
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Allergy Induced Asthma

Start date: 2005-11-01
Primary completion: 2009-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.